A patient on long-term high-dose morphine is switched to oxycodone for opioid rotation due to unacceptable side effects. During rotation, the calculated equianalgesic dose of oxycodone is deliberately reduced by 25–50%. The clinical rationale for this dose reduction is:

• A Oxycodone is a more potent opioid requiring less absolute dose
• B Oxycodone undergoes first-pass metabolism, reducing bioavailability compared to morphine
• C Incomplete cross-tolerance between opioids means the patient's previous tolerance does not fully transfer, and the new opioid may have more activity than expected at standard equianalgesic doses ✓
• D Oxycodone accumulates hepatically requiring lower maintenance doses

Explanation

Opioid rotation exploits the clinical phenomenon of incomplete cross-tolerance: tolerance developed to one opioid does not completely transfer to another opioid, even at equianalgesic doses. This is because different opioids have varying affinities for mu, kappa, and delta receptor subtypes, different receptor conformational states, different downstream signal transduction biases (G-protein vs. beta-arrestin), and different active metabolite profiles. Therefore, the patient may be more sensitive to the new opioid than expected. Standard practice is to reduce the calculated equianalgesic dose by 25–50% to avoid respiratory depression, especially when switching to a potent opioid like fentanyl or methadone.

Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.